alpesh amin, md, discusses study comparing doacs and warfarin
Published 7 years ago • 440 plays • Length 3:30Download video MP4
Download video MP3
Similar videos
-
25:22
new oral anticoagulants: update | samuel z. goldhaber, md
-
13:32
noacs should replace warfarin in all patients with atrial fibrillation - pro - j. camm
-
13:45
doacs vs warfarin - when to use one vs the other
-
51:46
effectiveness and safety of direct oral anticoagulants vs warfarin in patients with valvular afib
-
26:01
aineurocare - stroke and doacs
-
2:11
selecting patients with al amyloidosis for autohsct
-
24:34
novel oral anticoagulants: will they replace warfarin?
-
14:45
direct oral anticoagulants presentation - philip s. wells, md
-
0:39
how novel anticoagulants compare with warfarin for intraocular bleeding
-
2:56
how do drugs work: warfarin & novel oral anticoagulants
-
9:58
noacs should replace warfarin in all patients with atrial fibrillation - contra - p. widimsky
-
3:33
renato lopes, md, phd, of duke university discusses a sub-analysis of the aristotle trial
-
6:35
oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism
-
16:09
doacs in the anticoagulant treatment landscape
-
20:36
primer on traditional and novel anticoagulants | jeanine walenga, phd
-
24:28
new anticoagulants for stroke prevention in atrial fibrillation | christian ruff, md
-
4:07
direct oral anticoagulants (doacs) and the impact of 'antidotes' - cardioed lecture
-
25:02
new oral anticoagulants
-
3:34
steve deitelzweig, md: an analysis of the use of doacs